FDA Drug Approval, N019680, DEPAKOTE
FDA Drug Approval, N019680, DEPAKOTE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 019680
Company: ABBVIE
Drug Name: DEPAKOTE
Active Ingredients: DIVALPROEX SODIUM
Strength: EQ 125MG VALPROIC ACID
Dosage Form/Route: CAPSULE, DELAYED REL PELLETS;ORAL
Action Date: 09/12/1989
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Company: ABBVIE
Drug Name: DEPAKOTE
Active Ingredients: DIVALPROEX SODIUM
Strength: EQ 125MG VALPROIC ACID
Dosage Form/Route: CAPSULE, DELAYED REL PELLETS;ORAL
Action Date: 09/12/1989
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details